APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Praziquantel

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Praziquantel Market Outlook and Growth Opportunities 2026

Report ID 174027790419 December 2025204 pages

Choose your research edition.

Industry ResearchPraziquantel Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Praziquantel Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Praziquantel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Praziquantel Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Praziquantel Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Praziquantel market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Praziquantel market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Praziquantel market include Zoetis, Merck, Bayer, Soparfin, Shin Poong Pharm, Richter Pharma, Norbrook Laboratories, Merial and Mavlab Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Praziquantel market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Praziquantel and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Praziquantel sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Praziquantel market size, projected growth trends, production technologies, key applications, and end-use industries.

Praziquantel Segment by Company

Zoetis

Merck

Bayer

Soparfin

Shin Poong Pharm

Richter Pharma

Norbrook Laboratories

Merial

Mavlab Animal Health

Lavet Pharmaceuticals

Kyron Pharma

Krka

Ecuphar

Covetrus

CiplaVet

Chanelle Pharma

Ceva Santé Animale

C and H Generics

Auvex

AniMedica

Praziquantel Segment by Type

Patent

Generic

Praziquantel Segment by Application

Liver Fluke Infection

Cysticercosis

Cestode Infections

Trematode Infections

Schistosoma Infection

Others

Praziquantel Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Praziquantel status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Praziquantel market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Praziquantel significant trends, drivers, influence factors in global and regions.

6. To analyze Praziquantel competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Praziquantel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Praziquantel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Praziquantel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Praziquantel market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Praziquantel industry.

Chapter 3: Detailed analysis of Praziquantel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Praziquantel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Praziquantel in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Praziquantel Industry Trends Table 2. Praziquantel Industry Drivers Table 3. Praziquantel Industry Opportunities and Challenges Table 4. Praziquantel Industry Restraints Table 5. Global Praziquantel Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Praziquantel Revenue Share by Company (2021-2026) Table 7. Global Praziquantel Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Praziquantel Sales Volume Share by Company (2021-2026) Table 9. Global Praziquantel Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Praziquantel Company Ranking, (2024-2026) & (USD Million) Table 11. Global Praziquantel Key Company Manufacturing Base & Headquarters Table 12. Global Praziquantel Company, Product Type & Application Table 13. Global Praziquantel Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Praziquantel by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Patent Table 18. Significant Companies of Generic Table 19. Global Praziquantel Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Praziquantel Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Praziquantel Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Praziquantel Sales Volume Share by Type (2021-2026) Table 23. Global Praziquantel Sales Volume Share by Type (2027-2032) Table 24. Global Praziquantel Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Praziquantel Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Praziquantel Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Praziquantel Sales Value Share by Type (2021-2026) Table 28. Global Praziquantel Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Liver Fluke Infection Table 30. Significant Companies of Cysticercosis Table 31. Significant Companies of Cestode Infections Table 32. Significant Companies of Trematode Infections Table 33. Significant Companies of Schistosoma Infection Table 34. Significant Companies of Others Table 35. Global Praziquantel Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Praziquantel Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Praziquantel Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Praziquantel Sales Volume Share by Application (2021-2026) Table 39. Global Praziquantel Sales Volume Share by Application (2027-2032) Table 40. Global Praziquantel Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Praziquantel Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Praziquantel Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Praziquantel Sales Value Share by Application (2021-2026) Table 44. Global Praziquantel Sales Value Share by Application (2027-2032) Table 45. Global Praziquantel Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Praziquantel Sales by Region (2021-2026) & (K Units) Table 47. Global Praziquantel Sales Market Share by Region (2021-2026) Table 48. Global Praziquantel Sales by Region (2027-2032) & (K Units) Table 49. Global Praziquantel Sales Market Share by Region (2027-2032) Table 50. Global Praziquantel Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Praziquantel Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Praziquantel Sales Value Share by Region (2021-2026) Table 53. Global Praziquantel Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Praziquantel Sales Value Share by Region (2027-2032) Table 55. Global Praziquantel Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Praziquantel Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Praziquantel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Praziquantel Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Praziquantel Sales by Country (2021-2026) & (K Units) Table 60. Global Praziquantel Sales Market Share by Country (2021-2026) Table 61. Global Praziquantel Sales by Country (2027-2032) & (K Units) Table 62. Global Praziquantel Sales Market Share by Country (2027-2032) Table 63. Global Praziquantel Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Praziquantel Sales Value Market Share by Country (2021-2026) Table 65. Global Praziquantel Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Praziquantel Sales Value Market Share by Country (2027-2032) Table 67. Zoetis Company Information Table 68. Zoetis Business Overview Table 69. Zoetis Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Zoetis Praziquantel Product Portfolio Table 71. Zoetis Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Merck Praziquantel Product Portfolio Table 76. Merck Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bayer Praziquantel Product Portfolio Table 81. Bayer Recent Development Table 82. Soparfin Company Information Table 83. Soparfin Business Overview Table 84. Soparfin Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Soparfin Praziquantel Product Portfolio Table 86. Soparfin Recent Development Table 87. Shin Poong Pharm Company Information Table 88. Shin Poong Pharm Business Overview Table 89. Shin Poong Pharm Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Shin Poong Pharm Praziquantel Product Portfolio Table 91. Shin Poong Pharm Recent Development Table 92. Richter Pharma Company Information Table 93. Richter Pharma Business Overview Table 94. Richter Pharma Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Richter Pharma Praziquantel Product Portfolio Table 96. Richter Pharma Recent Development Table 97. Norbrook Laboratories Company Information Table 98. Norbrook Laboratories Business Overview Table 99. Norbrook Laboratories Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Norbrook Laboratories Praziquantel Product Portfolio Table 101. Norbrook Laboratories Recent Development Table 102. Merial Company Information Table 103. Merial Business Overview Table 104. Merial Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Merial Praziquantel Product Portfolio Table 106. Merial Recent Development Table 107. Mavlab Animal Health Company Information Table 108. Mavlab Animal Health Business Overview Table 109. Mavlab Animal Health Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Mavlab Animal Health Praziquantel Product Portfolio Table 111. Mavlab Animal Health Recent Development Table 112. Lavet Pharmaceuticals Company Information Table 113. Lavet Pharmaceuticals Business Overview Table 114. Lavet Pharmaceuticals Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Lavet Pharmaceuticals Praziquantel Product Portfolio Table 116. Lavet Pharmaceuticals Recent Development Table 117. Kyron Pharma Company Information Table 118. Kyron Pharma Business Overview Table 119. Kyron Pharma Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Kyron Pharma Praziquantel Product Portfolio Table 121. Kyron Pharma Recent Development Table 122. Krka Company Information Table 123. Krka Business Overview Table 124. Krka Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Krka Praziquantel Product Portfolio Table 126. Krka Recent Development Table 127. Ecuphar Company Information Table 128. Ecuphar Business Overview Table 129. Ecuphar Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Ecuphar Praziquantel Product Portfolio Table 131. Ecuphar Recent Development Table 132. Covetrus Company Information Table 133. Covetrus Business Overview Table 134. Covetrus Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Covetrus Praziquantel Product Portfolio Table 136. Covetrus Recent Development Table 137. CiplaVet Company Information Table 138. CiplaVet Business Overview Table 139. CiplaVet Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. CiplaVet Praziquantel Product Portfolio Table 141. CiplaVet Recent Development Table 142. Chanelle Pharma Company Information Table 143. Chanelle Pharma Business Overview Table 144. Chanelle Pharma Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Chanelle Pharma Praziquantel Product Portfolio Table 146. Chanelle Pharma Recent Development Table 147. Ceva Santé Animale Company Information Table 148. Ceva Santé Animale Business Overview Table 149. Ceva Santé Animale Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Ceva Santé Animale Praziquantel Product Portfolio Table 151. Ceva Santé Animale Recent Development Table 152. C and H Generics Company Information Table 153. C and H Generics Business Overview Table 154. C and H Generics Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. C and H Generics Praziquantel Product Portfolio Table 156. C and H Generics Recent Development Table 157. Auvex Company Information Table 158. Auvex Business Overview Table 159. Auvex Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Auvex Praziquantel Product Portfolio Table 161. Auvex Recent Development Table 162. AniMedica Company Information Table 163. AniMedica Business Overview Table 164. AniMedica Praziquantel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. AniMedica Praziquantel Product Portfolio Table 166. AniMedica Recent Development Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Praziquantel Distributors List Table 170. Praziquantel Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Praziquantel Product Image Figure 2. Global Praziquantel Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Praziquantel Sales Value (2021-2032) & (US$ Million) Figure 4. Global Praziquantel Sales (2021-2032) & (K Units) Figure 5. Global Praziquantel Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Praziquantel Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Patent Image Figure 10. Generic Image Figure 11. Global Praziquantel Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Praziquantel Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Praziquantel Sales Volume Share by Type (2021-2032) Figure 14. Global Praziquantel Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Praziquantel Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Praziquantel Sales Value Share by Type (2021-2032) Figure 17. Liver Fluke Infection Image Figure 18. Cysticercosis Image Figure 19. Cestode Infections Image Figure 20. Trematode Infections Image Figure 21. Schistosoma Infection Image Figure 22. Others Image Figure 23. Global Praziquantel Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Praziquantel Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Praziquantel Sales Volume Share by Application (2021-2032) Figure 26. Global Praziquantel Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Praziquantel Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Praziquantel Sales Value Share by Application (2021-2032) Figure 29. Global Praziquantel Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Praziquantel Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Praziquantel Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Praziquantel Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Praziquantel Sales Value (2021-2032) & (US$ Million) Figure 34. North America Praziquantel Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Praziquantel Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Praziquantel Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Praziquantel Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Praziquantel Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Praziquantel Sales Value (2021-2032) & (US$ Million) Figure 40. South America Praziquantel Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Praziquantel Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Praziquantel Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Praziquantel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Praziquantel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Praziquantel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Praziquantel Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Praziquantel Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • Liver Fluke Infection
  • Cysticercosis
  • Cestode Infections
  • Trematode Infections
  • Schistosoma Infection
  • Others
Companies covered
  • Zoetis
  • Merck
  • Bayer
  • Soparfin
  • Shin Poong Pharm
  • Richter Pharma
  • Norbrook Laboratories
  • Merial
  • Mavlab Animal Health
  • Lavet Pharmaceuticals
  • Kyron Pharma
  • Krka
  • Ecuphar
  • Covetrus
  • CiplaVet
  • Chanelle Pharma
  • Ceva Santé Animale
  • C and H Generics
  • Auvex
  • AniMedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Praziquantel Sales Value (2021-2032)
  4. 1.2.2 Global Praziquantel Sales Volume (2021-2032)
  5. 1.2.3 Global Praziquantel Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Praziquantel Market Dynamics
  1. 2.1 Praziquantel Industry Trends
  2. 2.2 Praziquantel Industry Drivers
  3. 2.3 Praziquantel Industry Opportunities and Challenges
  4. 2.4 Praziquantel Industry Restraints
3 Praziquantel Market by Company
  1. 3.1 Global Praziquantel Company Revenue Ranking in 2025
  2. 3.2 Global Praziquantel Revenue by Company (2021-2026)
  3. 3.3 Global Praziquantel Sales Volume by Company (2021-2026)
  4. 3.4 Global Praziquantel Average Price by Company (2021-2026)
  5. 3.5 Global Praziquantel Company Ranking (2024-2026)
  6. 3.6 Global Praziquantel Company Manufacturing Base and Headquarters
  7. 3.7 Global Praziquantel Company Product Type and Application
  8. 3.8 Global Praziquantel Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Praziquantel Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Praziquantel Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Praziquantel Market by Type
  1. 4.1 Praziquantel Type Introduction
  2. 4.1.1 Patent
  3. 4.1.2 Generic
  4. 4.2 Global Praziquantel Sales Volume by Type
  5. 4.2.1 Global Praziquantel Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Praziquantel Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Praziquantel Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Praziquantel Sales Value by Type
  9. 4.3.1 Global Praziquantel Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Praziquantel Sales Value by Type (2021-2032)
  11. 4.3.3 Global Praziquantel Sales Value Share by Type (2021-2032)
5 Praziquantel Market by Application
  1. 5.1 Praziquantel Application Introduction
  2. 5.1.1 Liver Fluke Infection
  3. 5.1.2 Cysticercosis
  4. 5.1.3 Cestode Infections
  5. 5.1.4 Trematode Infections
  6. 5.1.5 Schistosoma Infection
  7. 5.1.6 Others
  8. 5.2 Global Praziquantel Sales Volume by Application
  9. 5.2.1 Global Praziquantel Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Praziquantel Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Praziquantel Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Praziquantel Sales Value by Application
  13. 5.3.1 Global Praziquantel Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Praziquantel Sales Value by Application (2021-2032)
  15. 5.3.3 Global Praziquantel Sales Value Share by Application (2021-2032)
6 Praziquantel Regional Sales and Value Analysis
  1. 6.1 Global Praziquantel Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Praziquantel Sales by Region (2021-2032)
  3. 6.2.1 Global Praziquantel Sales by Region: 2021-2026
  4. 6.2.2 Global Praziquantel Sales by Region (2027-2032)
  5. 6.3 Global Praziquantel Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Praziquantel Sales Value by Region (2021-2032)
  7. 6.4.1 Global Praziquantel Sales Value by Region: 2021-2026
  8. 6.4.2 Global Praziquantel Sales Value by Region (2027-2032)
  9. 6.5 Global Praziquantel Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Praziquantel Sales Value (2021-2032)
  12. 6.6.2 North America Praziquantel Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Praziquantel Sales Value (2021-2032)
  15. 6.7.2 Europe Praziquantel Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Praziquantel Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Praziquantel Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Praziquantel Sales Value (2021-2032)
  21. 6.9.2 South America Praziquantel Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Praziquantel Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Praziquantel Sales Value Share by Country, 2025 VS 2032
7 Praziquantel Country-level Sales and Value Analysis
  1. 7.1 Global Praziquantel Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Praziquantel Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Praziquantel Sales by Country (2021-2032)
  4. 7.3.1 Global Praziquantel Sales by Country (2021-2026)
  5. 7.3.2 Global Praziquantel Sales by Country (2027-2032)
  6. 7.4 Global Praziquantel Sales Value by Country (2021-2032)
  7. 7.4.1 Global Praziquantel Sales Value by Country (2021-2026)
  8. 7.4.2 Global Praziquantel Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Praziquantel Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Praziquantel Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Praziquantel Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Praziquantel Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Praziquantel Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Praziquantel Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Praziquantel Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Praziquantel Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Praziquantel Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Praziquantel Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Praziquantel Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Praziquantel Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Praziquantel Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Praziquantel Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Praziquantel Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Praziquantel Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Praziquantel Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Praziquantel Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Praziquantel Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Praziquantel Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Praziquantel Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Praziquantel Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Praziquantel Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Praziquantel Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Praziquantel Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Praziquantel Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Praziquantel Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Praziquantel Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Praziquantel Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Praziquantel Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Praziquantel Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Praziquantel Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Praziquantel Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Praziquantel Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Praziquantel Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Praziquantel Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Praziquantel Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Praziquantel Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Praziquantel Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Praziquantel Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Praziquantel Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Praziquantel Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Praziquantel Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Praziquantel Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Praziquantel Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Praziquantel Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Praziquantel Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Praziquantel Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Praziquantel Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Praziquantel Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Praziquantel Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Praziquantel Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Praziquantel Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Praziquantel Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Praziquantel Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Praziquantel Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Praziquantel Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Praziquantel Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Praziquantel Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Praziquantel Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Praziquantel Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Praziquantel Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Praziquantel Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Praziquantel Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Praziquantel Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Praziquantel Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Praziquantel Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Praziquantel Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Praziquantel Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Praziquantel Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Praziquantel Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Praziquantel Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Praziquantel Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Praziquantel Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Praziquantel Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Praziquantel Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Praziquantel Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Praziquantel Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Praziquantel Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Praziquantel Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Praziquantel Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Praziquantel Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Praziquantel Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Praziquantel Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Praziquantel Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Praziquantel Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Praziquantel Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Praziquantel Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Praziquantel Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Praziquantel Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Soparfin
  20. 8.4.1 Soparfin Company Information
  21. 8.4.2 Soparfin Business Overview
  22. 8.4.3 Soparfin Praziquantel Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Soparfin Praziquantel Product Portfolio
  24. 8.4.5 Soparfin Recent Developments
  25. 8.5 Shin Poong Pharm
  26. 8.5.1 Shin Poong Pharm Company Information
  27. 8.5.2 Shin Poong Pharm Business Overview
  28. 8.5.3 Shin Poong Pharm Praziquantel Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shin Poong Pharm Praziquantel Product Portfolio
  30. 8.5.5 Shin Poong Pharm Recent Developments
  31. 8.6 Richter Pharma
  32. 8.6.1 Richter Pharma Company Information
  33. 8.6.2 Richter Pharma Business Overview
  34. 8.6.3 Richter Pharma Praziquantel Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Richter Pharma Praziquantel Product Portfolio
  36. 8.6.5 Richter Pharma Recent Developments
  37. 8.7 Norbrook Laboratories
  38. 8.7.1 Norbrook Laboratories Company Information
  39. 8.7.2 Norbrook Laboratories Business Overview
  40. 8.7.3 Norbrook Laboratories Praziquantel Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Norbrook Laboratories Praziquantel Product Portfolio
  42. 8.7.5 Norbrook Laboratories Recent Developments
  43. 8.8 Merial
  44. 8.8.1 Merial Company Information
  45. 8.8.2 Merial Business Overview
  46. 8.8.3 Merial Praziquantel Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merial Praziquantel Product Portfolio
  48. 8.8.5 Merial Recent Developments
  49. 8.9 Mavlab Animal Health
  50. 8.9.1 Mavlab Animal Health Company Information
  51. 8.9.2 Mavlab Animal Health Business Overview
  52. 8.9.3 Mavlab Animal Health Praziquantel Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mavlab Animal Health Praziquantel Product Portfolio
  54. 8.9.5 Mavlab Animal Health Recent Developments
  55. 8.10 Lavet Pharmaceuticals
  56. 8.10.1 Lavet Pharmaceuticals Company Information
  57. 8.10.2 Lavet Pharmaceuticals Business Overview
  58. 8.10.3 Lavet Pharmaceuticals Praziquantel Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lavet Pharmaceuticals Praziquantel Product Portfolio
  60. 8.10.5 Lavet Pharmaceuticals Recent Developments
  61. 8.11 Kyron Pharma
  62. 8.11.1 Kyron Pharma Company Information
  63. 8.11.2 Kyron Pharma Business Overview
  64. 8.11.3 Kyron Pharma Praziquantel Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Kyron Pharma Praziquantel Product Portfolio
  66. 8.11.5 Kyron Pharma Recent Developments
  67. 8.12 Krka
  68. 8.12.1 Krka Company Information
  69. 8.12.2 Krka Business Overview
  70. 8.12.3 Krka Praziquantel Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Krka Praziquantel Product Portfolio
  72. 8.12.5 Krka Recent Developments
  73. 8.13 Ecuphar
  74. 8.13.1 Ecuphar Company Information
  75. 8.13.2 Ecuphar Business Overview
  76. 8.13.3 Ecuphar Praziquantel Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Ecuphar Praziquantel Product Portfolio
  78. 8.13.5 Ecuphar Recent Developments
  79. 8.14 Covetrus
  80. 8.14.1 Covetrus Company Information
  81. 8.14.2 Covetrus Business Overview
  82. 8.14.3 Covetrus Praziquantel Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Covetrus Praziquantel Product Portfolio
  84. 8.14.5 Covetrus Recent Developments
  85. 8.15 CiplaVet
  86. 8.15.1 CiplaVet Company Information
  87. 8.15.2 CiplaVet Business Overview
  88. 8.15.3 CiplaVet Praziquantel Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CiplaVet Praziquantel Product Portfolio
  90. 8.15.5 CiplaVet Recent Developments
  91. 8.16 Chanelle Pharma
  92. 8.16.1 Chanelle Pharma Company Information
  93. 8.16.2 Chanelle Pharma Business Overview
  94. 8.16.3 Chanelle Pharma Praziquantel Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Chanelle Pharma Praziquantel Product Portfolio
  96. 8.16.5 Chanelle Pharma Recent Developments
  97. 8.17 Ceva Santé Animale
  98. 8.17.1 Ceva Santé Animale Company Information
  99. 8.17.2 Ceva Santé Animale Business Overview
  100. 8.17.3 Ceva Santé Animale Praziquantel Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Ceva Santé Animale Praziquantel Product Portfolio
  102. 8.17.5 Ceva Santé Animale Recent Developments
  103. 8.18 C and H Generics
  104. 8.18.1 C and H Generics Company Information
  105. 8.18.2 C and H Generics Business Overview
  106. 8.18.3 C and H Generics Praziquantel Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 C and H Generics Praziquantel Product Portfolio
  108. 8.18.5 C and H Generics Recent Developments
  109. 8.19 Auvex
  110. 8.19.1 Auvex Company Information
  111. 8.19.2 Auvex Business Overview
  112. 8.19.3 Auvex Praziquantel Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Auvex Praziquantel Product Portfolio
  114. 8.19.5 Auvex Recent Developments
  115. 8.20 AniMedica
  116. 8.20.1 AniMedica Company Information
  117. 8.20.2 AniMedica Business Overview
  118. 8.20.3 AniMedica Praziquantel Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 AniMedica Praziquantel Product Portfolio
  120. 8.20.5 AniMedica Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Praziquantel Value Chain Analysis
  2. 9.1.1 Praziquantel Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Praziquantel Sales Mode & Process
  6. 9.2 Praziquantel Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Praziquantel Distributors
  9. 9.2.3 Praziquantel Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst